The Department of Immunology is inviting applicants for a Senior Technician B position to study the molecular regulation of microRNA-139 in acute myeloid leukemia. The goal of this study is to understand the miRNA regulation at the transcriptional and post-transcriptional level. The candidate will further develop such as experimental mouse models and in vitro models, perform CRISPR-Cas9 screens, Next Generation Sequencing and generate retroviral expression vectors to manipulate activities of microRNA-139.

Candidates with a strong background and hands-on experience in molecular biology technology, cell biology, cell culture and mouse experiments will be considered. Candidates are expected to collaborate closely with scientists at the Immunology Department and within the Erasmus MC, be highly motivated and have a team spirit. Being able to present a certificate of good conduct is a condition for the appointment.

The gross monthly salary amounts a maximum of € 3.391,- (scale 8), depending on your level of education and relevant experience and based on a full-time working week of 36 hours. The terms of employment are in accordance with the Collective Bargaining Agreement for University Medical Centers (CAO UMC).

Erasmus MC

A healthy population and excellence in healthcare through research and education. This is what Erasmus MC stands for. Conducting groundbreaking work, pushing boundaries and leading the way. In research, education, and healthcare. We are practical people with a high level of expertise, working hard to improve and renew the healthcare of today and the public health of tomorrow.

The Department of Immunology performs cutting edge basic and translational research, participates in patient care by performing laboratory diagnostics (Laboratory for Medical Immunology) and supporting Clinical Immunology, and performs a wide range of educational activities. Major research focuses in the department span molecular to clinical immunology and includes the development and function of innate and adaptive immunity, autoimmunity, immune deficiencies, immunity to infection, neuroimmunology, and lymphoid malignancies. The department has state-of-the-art facilities and equipment that support basic and translational research. The department is involved in multiple International Consortia and networks, which facilitate innovation and rapid implementation of new immunological concepts and technologies.